Kite Pharma to Present at the 34th Annual J.P. Morgan Healthcare Conference

SANTA MONICA, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will present at the 34th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2016 at 8:30 AM Pacific Time.  The event will be held in San Francisco at the Westin St. Francis Hotel.

The presentation will be webcasted and will be available through the Calendar of Events section of Kite's website at ir.kitepharma.com.

About Kite Pharma, Inc.

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACTâ„¢) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

CONTACT: Kite Pharma, Inc.

Cynthia M. Butitta

Chief Financial Officer and Chief Operating Officer

310-824-9999



For Media: Justin Jackson

For Investor Inquiries: Lisa Burns

Burns McClellan

(212) 213-0006

jjackson@burnsmc.com

lburns@burnsmc.com

Source: Kite Pharma, Inc.

News Provided by Acquire Media